FTO-mediated SMAD2 m6A modification protects cartilage against Osteoarthritis
Abstract N6-methyladenosine (m6A) modification is one of the most prevalent forms of epigenetic modification and plays an important role in the development of degenerative diseases such as osteoarthritis (OA). However, the evidence concerning the role of m6A modification in OA is insufficient. Here,...
Saved in:
| Main Authors: | Hongyi Zhou, Ziang Xie, Yu Qian, Weiyu Ni, Lei Cui, Xiangqian Fang, Shuanglin Wan, Xiangde Zhao, An Qin, Shunwu Fan, Yizheng Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2024-10-01
|
| Series: | Experimental and Molecular Medicine |
| Online Access: | https://doi.org/10.1038/s12276-024-01330-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Honokiol inhibits human osteosarcoma MG63 cell migration by upregulating FTO and Smad6 to promote autophagy
by: Jian Wu, et al.
Published: (2024-12-01) -
FTO suppresses cardiac fibrosis after myocardial infarction via m6A-mediated epigenetic modification of EPRS
by: Jian Wang, et al.
Published: (2024-11-01) -
Mesenchymal Stem Cells for Cartilage Regeneration of TMJ Osteoarthritis
by: Dixin Cui, et al.
Published: (2017-01-01) -
O-GlcNAcylated FTO promotes m6A modification of SOX4 to enhance MDS/AML cell proliferation
by: Junjie Gou, et al.
Published: (2025-01-01) -
Single-cell transcriptomic analysis of chondrocytes in cartilage and pathogenesis of osteoarthritis
by: Changyuan Huang, et al.
Published: (2025-03-01)